Cranberry xyloglucan oligosaccharide composition

US9314494B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9314494-B2
Application numberUS-201213480903-A
CountryUS
Kind codeB2
Filing dateMay 25, 2012
Priority dateMay 25, 2012
Publication dateApr 19, 2016
Grant dateApr 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A composition prepared from a cranberry hull enzyme-treated composition which reduces or inhibits the adhesion of microorganisms to cells having α-Gal-(1-4)-Gal terminal oligosaccharide receptors for adhesion.

First claim

Opening claim text (preview).

We claim: 1. An anti-microbial composition, wherein said anti-microbial composition comprises a tablet or capsule having an effective amount of an anti-microbial adhesion inhibitory composition to inhibit the adhesions of bacteria to cells having α-Gal-(1-4)-β-Gal terminal oligosaccharide receptors for adhesion prepared by the method comprising the steps of: (a) providing cranberry hulls (b) treating said cranberry hulls with a pectinase in amounts sufficient to depectinize said hulls to form an enzyme treated composition, (c) removing debris from said enzyme treated composition using a method selected from the group consisting of decantation, centrifugation, and combinations thereof to form a first liquid, (d) spray drying said first liquid to form composition A1, (e) fractionating said composition A1 using C18 Flash Chromatography to produce composition A2 (f) freeze drying said composition A2 (g) purifying composition A2 using LH20 gel column chromatography to produce said anti-microbial adhesion inhibitory composition A6, (h) freeze drying said anti-microbial adhesion inhibitory composition A6 to produce a crystalline powder, (i) mixing said crystalline powder with a carrier to provide an anti-microbial adhesion inhibitory composition. 2. The composition of claim 1 , wherein said tablet or capsule comprises a medicament, a nutritional composition, or a pharmaceutical composition. 3. An anti-microbial composition, wherein said anti-microbial composition comprises a tablet or capsule having an effective amount of an anti-microbial adhesion inhibitory composition to inhibit the adhesions of bacteria to cells having α-Gal-(1-4)-β-Gal terminal oligosaccharide receptors for adhesion prepared comprising the steps of: (a) providing cranberry hulls (b) treating said cranberry hulls with a pectinase in amounts sufficient to depectinize said hulls to form an enzyme treated composition, (c) removing debris from said enzyme treated composition using a method selected from the group consisting of decantation, centrifugation, and combinations thereof to form a first liquid, (d) spray drying said first liquid to form composition A1, (e) fractionating said composition A1 using C18 Flash Chromatography to produce composition A2 (f) freeze drying said composition A2 (g) purifying fraction A2 LH20 using gel column chromatography to produce said anti-microbial adhesion inhibitory composition A6, (h) freeze drying said anti-microbial adhesion inhibitory composition A6 to produce a crystalline powder, (i) mixing said crystalline powder with a carrier to provide an anti-microbial adhesion inhibitory composition; wherein said anti-microbial adhesion inhibitory composition comprises arabino-xyloglucan with an SSG structure: 4. The composition of claim 3 , wherein said tablet or capsule comprises a medicament, a nutritional composition, or a pharmaceutical composition. 5. A method for reducing the adhesion of bacteria to cells having α-Gal-(1-4)-Gal terminal oligosaccharide receptors for adhesion comprising administering to said cells an effective amount of the composition of claim 1 or the composition of claim 3 .

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • Drugs for disorders of the urinary system · CPC title

  • Glucans · CPC title

  • A61K36/45Primary

    Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry · CPC title

  • Complex extraction schemes, e.g. fractionation or repeated extraction steps · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9314494B2 cover?
A composition prepared from a cranberry hull enzyme-treated composition which reduces or inhibits the adhesion of microorganisms to cells having α-Gal-(1-4)-Gal terminal oligosaccharide receptors for adhesion.
Who is the assignee on this patent?
Hotchkiss Arland T, Nunez Alberto, Khoo Christina, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61K36/45. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).